erythromycin/sulfafurazole

{{Short description|Combination drug}}

{{Drugbox

| type = combo

| component1 = Erythromycin

| class1 = Macrolide antibiotic

| component2 = Sulfafurazole

| class2 = Sulfonamide antibiotic

| tradename = Pediazole

| Drugs.com =

| MedlinePlus =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category=

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US = Rx-only

| legal_status =

| routes_of_administration = Oral

| CAS_number = 376597-07-8

| ATCvet =

| ATC_prefix =

| ATC_suffix =

| PubChem =

| DrugBank =

}}

Erythromycin/sulfafurazole (trade name Pediazole) is a combination drug with the antibiotics erythromycin and sulfafurazole (the latter is also known as sulfisoxazole).{{cn|date=February 2023}}

It is indicated in acute otitis media in children, particularly when Hemophilus influenzae is the suspected pathogen.[http://reference.medscape.com/drug/pediazole-erythromycin-base-sulfisoxazole-342546 erythromycin base/sulfisoxazole] at Medscape. Retrieved April 29, 2013. Patient handout: [http://reference.medscape.com/drug/pediazole-erythromycin-base-sulfisoxazole-342546#91].